Celltrion’s Remsima presented clinical study result led by Norwegian government

A result of the long-term clinical trial to research the Remsima’s substitute administration, ‘NOR-SWITCH Study’ was released at the United European Gastroenterology Week(UEGW) on the 18^th(local time) in Vienna, Austria.

Conducted by the Norwegian healthcare authorities, the NOR_SWITCH Study is a clinical trial product to assess safety and efficacy of the substitute administration of the orig...